Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
18.01
-0.58 (-3.12%)
At close: Apr 28, 2026, 4:00 PM EDT
17.65
-0.36 (-2.00%)
After-hours: Apr 28, 2026, 7:07 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.07 billion as of April 28, 2026. Its market cap has increased by 278.03% in one year.
Market Cap
1.07B
Enterprise Value
729.47M
1-Year Change
278.03%
Ranking
Category
Stock Price
$18.01
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.07B, an increase of 58.37%. That is a compound annual growth rate of 32.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.11B | -43.26% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.18B |
| Aktis Oncology | 1.18B |
| Pharming Group | 1.17B |
| UroGen Pharma | 1.17B |
| EyePoint | 1.15B |
| uniQure | 1.14B |
| Septerna | 1.11B |
| Inventiva | 1.06B |